Of note, antihypertensive pharmacological treatments were shown to have a beneficial role in elderly COVID-19 patients with comorbid hypertension since the clinical outcomes were significantly improved in the case of treatment with angiotensin receptor blockers (ARBs), ACE inhibitors, beta-blockers, or calcium channel blockers (CCBs) compared with patients who took no drugs [69]. The gene discussed is ACE; the disease is COVID-19.